Tobacco cessation program for community behavioral health sites in Chicago
Official title: Enhancing the Implementation of Tobacco Treatment: A Community-responsive Approach
Run by University of Chicago · NCT06837220 · Data updated 2026-11-12
This project will test a community-informed smoking cessation program to help adults who smoke and receive services at behavioral health organizations in Chicago.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 26 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | July 20, 2026 |
| Main results expected | December 2026 |
| Study ends | May 2027 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT06837220 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults (18+) in Chicago who smoke combustible cigarettes daily, are interested in quitting (at least 6/10), can understand English, provide consent, and have stable contact information and residence for follow-up.
✕Probably not a fit
People who do not smoke daily, are not interested in quitting, lack stable residence or will not remain in Chicago, or have untreated severe substance use or recent serious untreated psychiatric illness are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The team will form a Community Advisory Board of providers, organization leaders, and community members to guide program development. They will use mixed methods (interviews, focus groups, and surveys) to identify barriers, facilitators, and unmet needs for smoking cessation in community behavioral health settings. Based on those findings, the Enhanced Courage to Quit intervention will be adapted and pilot tested over a three-month rolling program at one community behavioral health site in partnership with the Respiratory Health Association. The pilot will measure feasibility and acceptability and address implementation challenges before broader rollout.
Why it matters
Potential benefit: If successful, the program could increase access to tailored cessation support and raise quit attempts among adults who smoke in behavioral health settings.
How similar studies have gone: Related community-informed and behavioral-health smoking cessation programs, including versions of Courage to Quit, have shown promising results in some settings, but piloting this targeted implementation in Chicago behavioral health sites is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month * Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting) * Age 18 or older, ability to understand the English language, willing and able to provide informed consent * Stable residence and contact information throughout the follow up period Exclusion Criteria: * Non-daily or intermittent cigarette use * No interest in quitting smoking * Unstable residence/not staying in Chicago for duration of study period * Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)
Where it's running
-
The University of Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Emma Brett, PhD
- Email: ebrett@bsd.uchicago.edu
- Phone: 773-834-5341
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
tDCS plus varenicline to help people quit smoking
This will test if adding noninvasive tDCS brain stimulation to varenicline helps adults who smoke at least 8 cigarettes a day quit and stay smoke-free.
-
Impact of Menstrual Cycle Phase on Smoking Cessation
This study tests if starting smoking cessation treatment during certain phases of the menstrual cycle helps women quit smoking more successfully.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Nicotine Orodispersible Tablet to Relieve Cravings in Smokers
A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.
-
Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking
This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.